RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Levon A. Bostanian to Administration, Oral

This is a "connection" page, showing publications Levon A. Bostanian has written about Administration, Oral.
Connection Strength

0.518
  1. Pramar YV, Mandal TK, Bostanian LA, Johnson J, Graves RA. Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):334-343.
    View in: PubMed
    Score: 0.058
  2. Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2023 Jul-Aug; 27(4):330-339.
    View in: PubMed
    Score: 0.054
  3. Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt. Int J Pharm Compd. 2023 Mar-Apr; 27(2):160-168.
    View in: PubMed
    Score: 0.053
  4. Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Int J Pharm Compd. 2021 Mar-Apr; 25(2):169-175.
    View in: PubMed
    Score: 0.046
  5. Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA. Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2020 Sep-Oct; 24(5):413-419.
    View in: PubMed
    Score: 0.044
  6. Graves RA, Mandal TK, Bostanian LA, Nguyen AT, Swopes D, Morris TC, Pramar YV. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2019 Nov-Dec; 23(6):519-527.
    View in: PubMed
    Score: 0.042
  7. Pramar YV, Mandal TK, Bostanian LA, Nguyen AT, Miller V, Morris TC, Graves RA. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2019 Jan-Feb; 23(1):70-76.
    View in: PubMed
    Score: 0.039
  8. Graves RA, Phan KV, Bostanian LA, Mandal TK, Pramar YV. Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt. Int J Pharm Compd. 2017 Sep-Oct; 21(5):430-435.
    View in: PubMed
    Score: 0.036
  9. Graves R, Phan KV, Bostanian LA, Mandal TK, Pramar YV. Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt. Int J Pharm Compd. 2017 Jul-Aug; 21(4):334-338.
    View in: PubMed
    Score: 0.036
  10. Ledet GA, Biswas S, Kumar VP, Graves RA, Mitchner DM, Parker TM, Bostanian LA, Ghosh SP, Mandal TK. Development of Orally Administered ?-Tocotrienol (GT3) Nanoemulsion for Radioprotection. Int J Mol Sci. 2016 Dec 24; 18(1).
    View in: PubMed
    Score: 0.034
  11. Graves RA, Ledet GA, Glotser EY, Mitchner DM, Bostanian LA, Mandal TK. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide. Eur J Pharm Sci. 2015 Aug 30; 76:1-9.
    View in: PubMed
    Score: 0.031
  12. Pamujula S, Graves RA, Moiseyev R, Bostanian LA, Kishore V, Mandal TK. Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation. J Pharm Pharmacol. 2008 Mar; 60(3):283-9.
    View in: PubMed
    Score: 0.019
  13. Pamujula S, Graves RA, Freeman T, Srinivasan V, Bostanian LA, Kishore V, Mandal TK. Oral delivery of spray dried PLGA/amifostine nanoparticles. J Pharm Pharmacol. 2004 Sep; 56(9):1119-25.
    View in: PubMed
    Score: 0.015
  14. Mandal TK, Bostanian LA, Graves RA, Chapman SR, Womack I. Development of biodegradable microcapsules as carrier for oral controlled delivery of amifostine. Drug Dev Ind Pharm. 2002 Mar; 28(3):339-44.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support